Search Results for: Intellia Therapeutics Demonstrates Pioneering CRIS
Articles
March 17, 2017
Intellia Therapeutics Demonstrates Pioneering CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery Technology March 17, 2017
Intellia Therapeutics, Inc., a leading genome editing company focused on the development of potentially curative therapies, recently reported updated data...
